IRVINE, Calif., May 2, 2019 — Ascendiant Capital Markets, LLC announced today the closing of a $10,700,000 Registered Direct Offering for Novus Therapeutics, Inc. (NasdaqCM: NVUS) of Irvine, California. For a copy of the announcement, please click here.